Abiopharma

ProQR Announces Second Quarter 2025 Operating and Financial Results

Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance

LENSAR Reports Second Quarter 2025 Results and Provides Business Update

Avalo Reports Second Quarter 2025 Financial Results and Recent Business Updates

Kiora Pharmaceuticals to Showcase Its Retinal Disease Therapeutic Pipeline at The H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

Insmed Reports Second-Quarter 2025 Financial Results and Provides Business Update

New Form 6-K - Haleon plc Filed: 2025-08-07 AccNo: 0001654954-25-009157 Size: 39 KB

New Form 10-Q - IMMUNIC, INC. Filed: 2025-08-07 AccNo: 0001280776-25-000012 Size: 12 MB

New Form 8-K - Warby Parker Inc. Filed: 2025-08-07 AccNo: 0001504776-25-000024 Size: 456 KB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

Warby Parker - Warby Parker Announces Second Quarter 2025 Results

Warby Parker Announces Second Quarter 2025 Results

Lilly reports second-quarter 2025 financial results and raises guidance

New Form 10-Q - Nuvalent, Inc. Filed: 2025-08-07 AccNo: 0000950170-25-104532 Size: 8 MB

New Form 8-K - IMMUNIC, INC. Filed: 2025-08-07 AccNo: 0001193805-25-001164 Size: 16 MB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - BECTON DICKINSON & CO Filed: 2025-08-07 AccNo: 0000010795-25-000069 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits